These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 36765782)

  • 21. Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment.
    Gao Z; Bai Y; Lin A; Jiang A; Zhou C; Cheng Q; Liu Z; Chen X; Zhang J; Luo P
    Mol Cancer; 2023 Feb; 22(1):31. PubMed ID: 36793048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice.
    Lasorsa F; di Meo NA; Rutigliano M; Milella M; Ferro M; Pandolfo SD; Crocetto F; Tataru OS; Autorino R; Battaglia M; Ditonno P; Lucarelli G
    Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of inhibitory immune checkpoints and relevant regulatory pathways in breast cancer stem cells.
    Shi H; Yang Y
    Cancer Med; 2021 Jun; 10(11):3794-3807. PubMed ID: 33932112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms underlying response and resistance to immune checkpoint blockade in cancer immunotherapy.
    Lee J; Kim EH
    Front Oncol; 2023; 13():1233376. PubMed ID: 37614504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The miRNA Profile of Inflammatory Colorectal Tumors Identify TGF-β as a Companion Target for Checkpoint Blockade Immunotherapy.
    Bartlett B; Gao Z; Schukking M; Menor M; Khadka VS; Fabbri M; Fei P; Deng Y
    Front Cell Dev Biol; 2021; 9():754507. PubMed ID: 34722540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. If small molecules immunotherapy comes, can the prime be far behind?
    Zhang J; Zhang Y; Qu B; Yang H; Hu S; Dong X
    Eur J Med Chem; 2021 Jun; 218():113356. PubMed ID: 33773287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Future of immune checkpoint inhibitors: focus on tumor immune microenvironment.
    Jia Y; Liu L; Shan B
    Ann Transl Med; 2020 Sep; 8(17):1095. PubMed ID: 33145314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can Combined Therapy Benefit Immune Checkpoint Blockade Response in Hepatocellular Carcinoma?
    Zhongqi F; Xiaodong S; Yuguo C; Guoyue L
    Anticancer Agents Med Chem; 2019; 19(2):222-228. PubMed ID: 30426903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted Therapy of B7 Family Checkpoints as an Innovative Approach to Overcome Cancer Therapy Resistance: A Review from Chemotherapy to Immunotherapy.
    Amir Taghavi B; Alizadeh N; Saeedi H; Karim Ahangar N; Derakhshani A; Hajiasgharzadeh K; Silvestris N; Baradaran B; Brunetti O
    Molecules; 2022 May; 27(11):. PubMed ID: 35684481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical efficacy of combination therapy of an immune checkpoint inhibitor with taxane plus platinum versus an immune checkpoint inhibitor with fluorouracil plus platinum in the first-line treatment of patients with locally advanced, metastatic, or recurrent esophageal squamous cell carcinoma.
    Li Y; Ji Y; Shen L; Yin X; Huang T; Deng B; Guo H; Wu Y; Chen Y
    Front Oncol; 2022; 12():1015302. PubMed ID: 36605427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noncoding RNAs and immune checkpoints-clinical implications as cancer therapeutics.
    Smolle MA; Calin HN; Pichler M; Calin GA
    FEBS J; 2017 Jul; 284(13):1952-1966. PubMed ID: 28132417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photothermal therapies to improve immune checkpoint blockade for cancer.
    Balakrishnan PB; Sweeney EE; Ramanujam AS; Fernandes R
    Int J Hyperthermia; 2020 Dec; 37(3):34-49. PubMed ID: 33426992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoadjuvant immune checkpoint blockade triggers persistent and systemic T
    Blomberg OS; Kos K; Spagnuolo L; Isaeva OI; Garner H; Wellenstein MD; Bakker N; Duits DEM; Kersten K; Klarenbeek S; Hau CS; Kaldenbach D; Raeven EAM; Vrijland K; Kok M; de Visser KE
    Oncoimmunology; 2023; 12(1):2201147. PubMed ID: 37089449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune Checkpoint Inhibitors and Novel Immunotherapy Approaches for Breast Cancer.
    Cejuela M; Vethencourt A; Pernas S
    Curr Oncol Rep; 2022 Dec; 24(12):1801-1819. PubMed ID: 36255603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Harnessing the capacity of phytochemicals to enhance immune checkpoint inhibitor therapy of cancers: A focus on brain malignancies.
    Afshari AR; Sanati M; Ahmadi SS; Kesharwani P; Sahebkar A
    Cancer Lett; 2024 Jul; 593():216955. PubMed ID: 38750720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PD-1/PD-L1 Blockade Therapy in Advanced Non-Small-Cell Lung Cancer: Current Status and Future Directions.
    Xia L; Liu Y; Wang Y
    Oncologist; 2019 Feb; 24(Suppl 1):S31-S41. PubMed ID: 30819829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New therapeutic targets for cancer: the interplay between immune and metabolic checkpoints and gut microbiota.
    Agrawal B
    Clin Transl Med; 2019 Aug; 8(1):23. PubMed ID: 31468283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomarkers of Immune Checkpoint Blockade Response in Triple-Negative Breast Cancer.
    Isaacs J; Anders C; McArthur H; Force J
    Curr Treat Options Oncol; 2021 Mar; 22(5):38. PubMed ID: 33743085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular toxicity profiles of immune checkpoint inhibitors with or without angiogenesis inhibitors: a real-world pharmacovigilance analysis based on the FAERS database from 2014 to 2022.
    Wang Y; Cui C; Deng L; Wang L; Ren X
    Front Immunol; 2023; 14():1127128. PubMed ID: 37292205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phytochemicals in Cancer Immune Checkpoint Inhibitor Therapy.
    Lee J; Han Y; Wang W; Jo H; Kim H; Kim S; Yang KM; Kim SJ; Dhanasekaran DN; Song YS
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.